KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Non-Current Assets (2019 - 2025)

Clover Health Investments (CLOV) has disclosed Non-Current Assets for 7 consecutive years, with $233.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 1.88% year-over-year to $233.2 million, compared with a TTM value of $926.3 million through Dec 2025, up 1360.96%, and an annual FY2025 reading of $233.2 million, down 1.88% over the prior year.
  • Non-Current Assets was $233.2 million for Q4 2025 at Clover Health Investments, up from $228.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $498.2 million in Q2 2021 and bottomed at -$536.8 million in Q1 2023.
  • Average Non-Current Assets over 5 years is $65.2 million, with a median of $165.6 million recorded in 2022.
  • The sharpest move saw Non-Current Assets plummeted 384.8% in 2023, then skyrocketed 15390.04% in 2025.
  • Year by year, Non-Current Assets stood at $198.3 million in 2021, then plummeted by 236.31% to -$270.2 million in 2022, then surged by 152.8% to $142.7 million in 2023, then soared by 66.51% to $237.6 million in 2024, then dropped by 1.88% to $233.2 million in 2025.
  • Business Quant data shows Non-Current Assets for CLOV at $233.2 million in Q4 2025, $228.7 million in Q3 2025, and $212.0 million in Q2 2025.